8-K
XBRL
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K
- Filed
- January 31, 2024
- Period of Report
- January 31, 2024
- Accession Number
- 0001157523-24-000137
An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →